MX2015014892A - Metodo para un ensayo de deteccion de farmacos basado en celulas y el uso del mismo. - Google Patents

Metodo para un ensayo de deteccion de farmacos basado en celulas y el uso del mismo.

Info

Publication number
MX2015014892A
MX2015014892A MX2015014892A MX2015014892A MX2015014892A MX 2015014892 A MX2015014892 A MX 2015014892A MX 2015014892 A MX2015014892 A MX 2015014892A MX 2015014892 A MX2015014892 A MX 2015014892A MX 2015014892 A MX2015014892 A MX 2015014892A
Authority
MX
Mexico
Prior art keywords
cell
screening assay
time
drug screening
based drug
Prior art date
Application number
MX2015014892A
Other languages
English (en)
Other versions
MX366369B (es
Inventor
Simone Rizzi
Guillaume Jacot
Matthias Lutolf
Original Assignee
Qgel Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qgel Sa filed Critical Qgel Sa
Publication of MX2015014892A publication Critical patent/MX2015014892A/es
Publication of MX366369B publication Critical patent/MX366369B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Abstract

La presente invención se refiere a un ensayo de detección de fármacos basado en células que comprende los pasos de: (i) cultivar una población de células en un ambiente de cultivo, (ii) definir por lo menos dos puntos de monitoreo en el tiempo en dependencia de por lo menos uno de los tipos de células, las características fisiológicas de las células, las características fisiológicas del tejido formado, el modo de acción de un principio activo y el ambiente de cultivo, (iii) aplicar principios activos a las células cultivadas por lo menos en un punto de tratamiento en el tiempo, (iv) monitorear el efecto de dicho principio activo en las células o tejidos formados por lo menos a dichos dos puntos de monitoreo en el tiempo.
MX2015014892A 2013-04-25 2014-04-22 Metodo para un ensayo de deteccion de farmacos basado en celulas y el uso del mismo. MX366369B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13165419.6A EP2796873A1 (en) 2013-04-25 2013-04-25 Method for a cell-based drug screening assay and the use thereof
PCT/EP2014/058152 WO2014173907A1 (en) 2013-04-25 2014-04-22 Method for a cell-based drug screening assay and the use thereof

Publications (2)

Publication Number Publication Date
MX2015014892A true MX2015014892A (es) 2016-03-07
MX366369B MX366369B (es) 2019-07-05

Family

ID=48326111

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015014892A MX366369B (es) 2013-04-25 2014-04-22 Metodo para un ensayo de deteccion de farmacos basado en celulas y el uso del mismo.

Country Status (14)

Country Link
US (1) US20160077081A1 (es)
EP (2) EP2796873A1 (es)
JP (1) JP6484219B2 (es)
KR (1) KR102255944B1 (es)
CN (1) CN105143883B (es)
AU (1) AU2014257584B2 (es)
BR (1) BR112015026601B1 (es)
CA (1) CA2910146C (es)
ES (1) ES2729341T3 (es)
IL (1) IL242172B (es)
MX (1) MX366369B (es)
RU (1) RU2702643C2 (es)
SG (1) SG11201508611WA (es)
WO (1) WO2014173907A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011140441A2 (en) 2010-05-06 2011-11-10 Children's Hospital Medical Center Methods and systems for converting precursor cells into intestinal tissues through directed differentiation
SG10201801654RA (en) 2014-05-28 2018-04-27 Childrens Hospital Med Ct Methods and systems for converting precursor cells into gastric tissues through directed differentiation
EP3207123A1 (en) 2014-10-17 2017-08-23 Children's Hospital Center D/b/a Cincinnati Children's Hospital Medical Center In vivo model of human small intestine using pluripotent stem cells and methods of making and using same
JP2016136848A (ja) * 2015-01-26 2016-08-04 富士フイルム株式会社 薬剤の評価方法及び薬剤スクリーニング方法
GB201514864D0 (en) * 2015-08-20 2015-10-07 Insphero Ag An in vitro 3D cell culture model-based tumor relapse assay
WO2017192997A1 (en) 2016-05-05 2017-11-09 Children's Hospital Medical Center Methods for the in vitro manufacture of gastric fundus tissue and compositions related to same
KR101916801B1 (ko) * 2016-08-12 2018-11-08 경북대학교 산학협력단 3차원 생체 모사 시스템을 이용한 맥락막 혈관신생을 수반하는 질환의 치료제 스크리닝 방법
IT201600099380A1 (it) * 2016-10-04 2018-04-04 Univ Bologna Alma Mater Studiorum Composizioni, dispositivi e metodi per il controllo in vitro del microambiente chimico in colture cellulari
SG10202105768WA (en) 2016-12-05 2021-06-29 Childrens Hospital Med Ct Colonic organoids and methods of making and using same
JP7405373B2 (ja) 2018-10-05 2023-12-26 国立大学法人東海国立大学機構 化学物質のスクリーニング方法、プログラム、制御装置、及び培養観察装置
GB201818885D0 (en) * 2018-11-20 2019-01-02 Precomb Therapeutics Ag 3d human cancer model-based combinatiorial drug development method

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728541A (en) * 1996-07-12 1998-03-17 Precision Therapeutics, Inc. Method for preparing cell cultures from biologial specimens for chemotherapeutic and other assays
JP4198468B2 (ja) * 2001-04-03 2008-12-17 バイオセプト インコーポレイテッド 生細胞および有機分子をカプセル封入するための方法およびゲル組成物
AU2005253923A1 (en) * 2004-06-08 2005-12-29 Primegen Biotech Llc Therapeutic reprogramming, hybrid stem cells and maturation
US20090324596A1 (en) * 2008-06-30 2009-12-31 The Trustees Of Princeton University Methods of identifying and treating poor-prognosis cancers
EP2342317B1 (en) 2008-09-22 2012-12-19 University Of Zurich Prorektorat Forschung Hanging drop plate
US8802702B2 (en) * 2009-01-15 2014-08-12 The General Hospital Corporation Compounds for reducing drug resistance and uses thereof
US20110004414A1 (en) * 2009-06-06 2011-01-06 Ceetox, Inc. Method for Predicting Respiratory Toxicity of Compounds
EP2380920A1 (en) * 2010-04-22 2011-10-26 QGel SA Hydrogel precursor formulation and production process thereof
CN103328626B (zh) * 2010-10-06 2017-02-08 中外制药株式会社 癌干细胞群及其制备方法
JP6028236B2 (ja) * 2011-09-12 2016-11-16 国立大学法人 熊本大学 物質のスクリーニング方法

Also Published As

Publication number Publication date
CN105143883B (zh) 2018-10-23
MX366369B (es) 2019-07-05
RU2702643C2 (ru) 2019-10-09
AU2014257584A1 (en) 2015-11-05
BR112015026601B1 (pt) 2023-11-21
EP2989460A1 (en) 2016-03-02
WO2014173907A1 (en) 2014-10-30
RU2015150203A (ru) 2017-05-31
SG11201508611WA (en) 2015-11-27
EP2796873A1 (en) 2014-10-29
JP2016518129A (ja) 2016-06-23
KR102255944B1 (ko) 2021-05-25
CA2910146A1 (en) 2014-10-30
BR112015026601A2 (pt) 2017-07-25
ES2729341T3 (es) 2019-10-31
KR20160003761A (ko) 2016-01-11
US20160077081A1 (en) 2016-03-17
IL242172B (en) 2019-03-31
CN105143883A (zh) 2015-12-09
EP2989460B1 (en) 2019-03-06
AU2014257584B2 (en) 2020-05-14
JP6484219B2 (ja) 2019-03-13
CA2910146C (en) 2024-04-09

Similar Documents

Publication Publication Date Title
MX366369B (es) Metodo para un ensayo de deteccion de farmacos basado en celulas y el uso del mismo.
CY1123142T1 (el) Βελτιωμενες μεθοδοι για την παραγωγη θετων κυτταρικων θεραπειων
EP4306636A3 (en) Monolayer of pbmcs or bone-marrow cells and uses thereof
NZ765695A (en) Immune cell organoid co-cultures
WO2016015058A3 (en) Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
MY171710A (en) Culture medium composition, and method for culturing cell or tissue using said composition
MX2021005777A (es) Suministro selectivo de material a celulas.
WO2016172454A8 (en) Microfluidic cell culture
TR201904270T4 (tr) Tanımlı koşullar altında insan pluripotent kök hücrelerinin hematoendotelyal farklılaşması için yöntemler ve materyaller.
GB2562396A (en) Devices for simulating a function of a liver tissue and methods of use and manufacturing thereof
BR112014028881A2 (pt) populações de células, banco de células, métodos de obtenção de uma população de células, métodos de identificação de um fator, métodos de seleção, métodos de fornecimento de terapia, populações de hepatócitos e método de obtenção de células
MX2015018035A (es) Metodos para predecir respuestas a sustancias quimicas o biologicas.
RS54525B1 (en) DLBCL TREATMENT MEANS AND PROCEDURES
CY1120800T1 (el) Μεθοδοι και συνθεσεις για την in vivo ενεργοποιηση του σχηματισμου παγκρεατικων βητα κυτταρων
MX2022003399A (es) Metodo basado en celulas para determinar la potencia de la defibrotida.
EP3608400A4 (en) CELL POPULATION WITH MESENCHYMAL STEM CELLS, METHOD OF MANUFACTURING THEREFORE AND PHARMACEUTICAL COMPOSITION
MX2015008436A (es) Composiciones para permeabilizar celulas sanguineos fijos y sus usos.
WO2015003160A3 (en) Hepatocytes in co-culture and uses thereof
GB2508782A (en) Facile laboratory method for localising biomolecules to the surface of cells and viruses
EP3620529A4 (en) PROCESS FOR MONITORING DYNAMIC CHANGES IN CELLS OR A SUBSTANCE DERIVED THEREOF, AND PROCESS FOR CELL CLASSIFICATION USING THIS MONITORING PROCEDURE
MX2018005228A (es) Un metodo ex vivo para ensayar la respuesta de poblaciones celulares primarias a un farmaco o combinacion de farmacos.
UA78641U (ru) Способ прогнозирования тяжести больных острым панкреатитом
EP2610337A4 (en) MASS TEST OF BLOOD CELL BLOOD CELLS USING CELL COAGULATION, ADULT BLOOD STEM CELLS USING THE SAME, METHOD OF EXPANDING PROGENITOR CELLS AND STEM CELLS PRODUCED USING THE METHOD
WO2015051166A3 (en) Use of cox-3 binding molecules for modulating autophagy
WO2015017535A3 (en) Cell-based control and method

Legal Events

Date Code Title Description
FG Grant or registration